Clinical Trial: A Multicentre, Prospective, Open-label Randomised Controlled Clinical Study Comparing the Efficacy and Safety of NRT6003 Injection and Traditional Meridian Embolism in Patients with Non-operable Hepatocellular Cancer in China

U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06909708) titled 'A Multicentre, Prospective, Open-label Randomised Controlled Clinical Study Comparing the Efficacy and Safety of NRT6003 Injection and Traditional Meridian Embolism in Patients with Non-operable Hepatocellular Cancer in China' on March 26.

Brief Summary: The clinical study, titled "A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Trial Comparing NRT6003 Injection with Conventional Transarterial Chemoembolization (cTACE) in Chinese Patients with Unresectable Hepatocellular Carcinoma (HCC) to Evaluate Efficacy and Safety" , aims to assess the effectiveness and safety of NRT6003 Injection versus cTACE in unresecta...